Allison JR, Curtis AC. Vitiligo and pernicious anemia. Arch Dermatol 1955;72:407-8.
Allison JR. The relation of HCl and vitamin B complex deficiency in certain skin diseases. South Med J 38:235-41, 1945.
Antoniou C et al. Vitiligo therapy with oral and topical phenylalanine with
UVA exposure. Int J Dermatol 1989;28(8):545-7.
Biella U, Haustein UF. Treatment of vitiligo using phenylalanine and UVA radiation. Hautarzt 41(11):636, 1990 (in German)
Cormane RH et al. Phenylalanine and UVA light for the treatment of vitiligo. Arch Dermatol Res 1985; 277(2):126-30.
Chorazak T, Rzempoluch E. Etiopathogenesis of vitiligo in the light of our studies. Pol Med J 1968;7(2):494-500.
Faas L, Venkatasamy R, Hider RC, et al. In vivo evaluation of piperine and synthetic analogues as potential treatments for vitiligo using a sparsely pigmented mouse model. Br J Dermatol 2008;158(5):941-50
Francis HW. Achlorhydria as an etiological factor in vitiligo, with report of four cases. Nebraska Med J 1931;16:25-6.
Genov D et al. Copper pathochemistry in vitiligo. Clin Chim Acta 1972; 37:207-11.
Howitz J, Schwartz M. Vitiligo, achlorhydria, and pernicious anemia. Lancet i:1331-5, 1971.
Hughes CG. Oral PABA and vitiligo. Letter. J Am Acad Dermatol 9(5):770, 1983.
Ishida K. Jpn J Dermatol Venerol 64:155, 1954
Kantor GR, Ratz JL. Liver toxicity from potassium para-aminobenzoate. Letter. J Am
Acad Dermatol 13(4):671-2, 1985.
Kim HI et al. Two cases of nickel dermatitis showing vitiligo-like depigmentations. Yonsei Med J 32(1):79-81, 1991.
Kuiters GR et al. Oral phenylalanine loading and sunlight as source of UVA irradiation in vitiligo on the Caribbean island of Curacao NA. J Trop Med Hyg 89(3):149-55, 1986.
Lal S et al. Serum caeruloplasmin in vitiligo. Indian J Med Sci 24(10):678-9, 1970;
Montes LF, Diaz ML, Lajous J, Garcia NJ. Folic acid and vitamin B12 in vitiligo: a nutritional approach. Cutis 50:39-42, 1992.
Schulpis CH et al. Phenylalanine plus ultraviolet light: preliminary report of a promising treatment for childhood vitiligo. Pediatr Dermatol 6(4):332-5, 1989.
Sen S. Caeruloplasmin, copper and disease. J Indian Med Assoc 52(4):182-4, 1969.
Siddiqui AH, Stolk LM, Bhaggoe R, et al. L-phenylalanine and UVA irradiation in the
treatment of vitiligo. Dermatology 188(3):215-18, 1994.
Sieve BF. The clinical effects of a new B complex factor, para-aminobenzoic
acid, on pigmentation and fertility. South Med Surg 104:135-9, 1942.
Sieve BF. Further investigations in the treatment of vitiligo. Virginia Med Monthly January 1945, pp. 6-17.
Song Y-H, Connor E, Li Y, et al. The role of tyrosinase in autoimmune vitiligo. Lancet 344:1049-52, 1994.
Thiele B, Steigleder GK. Repigmentation treatment of vitiligo with
L-phenylalanine and UVA radiation. Z Hautkr 62(7):519-23, 1987 (in German).
